MedKoo Cat#: 562713 | Name: Shield-1 Tosylate
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Shield-1 Tosylate is a water soluble version of Shield-1. It acts by binding tightly to FKBP, displacing the degron and inducing rapid and processive degradation of the LID domain and any fused partner protein.

Chemical Structure

Shield-1 Tosylate
CAS#914805-33-7 (free base)

Theoretical Analysis

MedKoo Cat#: 562713

Name: Shield-1 Tosylate

CAS#: 914805-33-7 (free base)

Chemical Formula: C49H64N2O13S

Exact Mass: 0.0000

Molecular Weight: 921.11

Elemental Analysis: C, 63.89; H, 7.00; N, 3.04; O, 22.58; S, 3.48

Price and Availability

Size Price Availability Quantity
10mg USD 450.00 2 Weeks
25mg USD 750.00 2 Weeks
100mg USD 1,950.00 2 Weeks
1g USD 4,950.00 2 Weeks
2g USD 8,950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Shield-1 Tosylate; Shield 1 Tosylate; Shield1 Tosylate; AquaShield-1; AquaShield 1; AquaShield1;
IUPAC/Chemical Name
(S)-(R)-3-(3,4-Dimethoxyphenyl)-1-(3-(2-morpholinoethoxy)phenyl)propyl 1-((S)-2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carboxylate Tosylate
InChi Key
RGQLXMGMLXCQRQ-YQWFAZLASA-N
InChi Code
InChI=1S/C42H56N2O10.C7H8O3S/c1-7-33(31-27-38(49-4)40(51-6)39(28-31)50-5)41(45)44-18-9-8-13-34(44)42(46)54-35(16-14-29-15-17-36(47-2)37(25-29)48-3)30-11-10-12-32(26-30)53-24-21-43-19-22-52-23-20-43;1-6-2-4-7(5-3-6)11(8,9)10/h10-12,15,17,25-28,33-35H,7-9,13-14,16,18-24H2,1-6H3;2-5H,1H3,(H,8,9,10)/t33-,34+,35-;/m0./s1
SMILES Code
OS(=O)(C1=CC=C(C)C=C1)=O.O=C([C@@H]2N(C([C@H](C3=CC(OC)=C(OC)C(OC)=C3)CC)=O)CCCC2)O[C@H](C4=CC=CC(OCCN5CCOCC5)=C4)CCC6=CC=C(OC)C(OC)=C6
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 921.11 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Madsen D, Jørgensen FP, Palmer D, Roux ME, Olsen JV, Bols M, Schoffelen S, Diness F, Meldal M. Design and Combinatorial Development of Shield-1 Peptide Mimetics Binding to Destabilized FKBP12. ACS Comb Sci. 2020 Mar 9;22(3):156-164. doi: 10.1021/acscombsci.9b00197. Epub 2020 Feb 23. PMID: 32027120. 2: Banaszynski LA, Chen LC, Maynard-Smith LA, Ooi AG, Wandless TJ. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell. 2006 Sep 8;126(5):995-1004. doi: 10.1016/j.cell.2006.07.025. PMID: 16959577; PMCID: PMC3290523. 3: Froschauer A, Kube L, Kegler A, Rieger C, Gutzeit HO. Tunable Protein Stabilization In Vivo Mediated by Shield-1 in Transgenic Medaka. PLoS One. 2015 Jul 6;10(7):e0131252. doi: 10.1371/journal.pone.0131252. PMID: 26148066; PMCID: PMC4493054. 4: Zmora O, Fleshner P, Barie PS, Segev L, Viola GM, Senagore AJ, Spinelli A, Belotserkovsky O, Sharoni S, Emanuel N; SHIELD 1 Investigators. Effect of local prolonged-release incisional doxycycline on surgical site infection prophylaxis in abdominal colorectal surgery: the SHIELD 1 randomized clinical trial. Int J Surg. 2024 Oct 1;110(10):6658-6666. doi: 10.1097/JS9.0000000000001824. PMID: 38869970; PMCID: PMC11486998. 5: Dogramaci M, Butt MA. The Influence of Slit Lamp Shield Size and Design in Reducing Aerosol Transmission. Transl Vis Sci Technol. 2021 Nov 1;10(13):33. doi: 10.1167/tvst.10.13.33. Erratum in: Transl Vis Sci Technol. 2022 Jan 3;11(1):21. doi: 10.1167/tvst.11.1.21. PMID: 34846521; PMCID: PMC8648061. 6: Khan MA, Ashraf G, Ashraf H, Francis IC, Wilcsek G. Efficacy of patient-sided breath shields for slit-lamp examination. Can J Ophthalmol. 2023 Aug;58(4):369-374. doi: 10.1016/j.jcjo.2022.02.002. Epub 2022 Feb 27. PMID: 35231395. 7: Xu Y, Wang Y, Liang FS. Site-Specific m6 A Erasing via Conditionally Stabilized CRISPR-Cas13b Editor. Angew Chem Int Ed Engl. 2023 Oct 23;62(43):e202309291. doi: 10.1002/anie.202309291. Epub 2023 Sep 15. PMID: 37713087; PMCID: PMC10592254. 8: Hong DP, Radke JB, White MW. Opposing Transcriptional Mechanisms Regulate Toxoplasma Development. mSphere. 2017 Feb 22;2(1):e00347-16. doi: 10.1128/mSphere.00347-16. PMID: 28251183; PMCID: PMC5322347. 9: Mohamed NN, El-Anwar MW. New Metal Shield for the Endotracheal Tube during Laser Endolaryngeal Surgery. Iran J Otorhinolaryngol. 2018 Sep;30(100):291-295. PMID: 30245983; PMCID: PMC6147269. 10: Schoeber JP, van de Graaf SF, Lee KP, Wittgen HG, Hoenderop JG, Bindels RJ. Conditional fast expression and function of multimeric TRPV5 channels using Shield-1. Am J Physiol Renal Physiol. 2009 Jan;296(1):F204-11. doi: 10.1152/ajprenal.90473.2008. Epub 2008 Oct 8. PMID: 18842822.